Critical ATP parameters associated with blood and mammalian cells: Relevant measurement techniques

Drug Development Research

Volumn 59, Issue 1, 2003, Pages 152-160

  Abraham, Edward H ^a,b,c   Salikhova, Anna Y ^a,b   Hug, Eugen B ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b Adenylate Diagnostics   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Adenosine 5 triphosphate (ATP) parameters; Luciferin luciferase luminometric assay; Plasma ATP; Total blood ATP; Total cellular ATP release rates

Indexed keywords

ADENOSINE TRIPHOSPHATE; EDETIC ACID; LUCIFERASE; LUCIFERIN;

ALGORITHM; ASSAY; BLOOD LEVEL; CELL SECRETION; COMPUTER PROGRAM; CONFERENCE PAPER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; LUMINOMETRY; MAMMAL CELL; MEASUREMENT; PLASMA; SENSITIVITY AND SPECIFICITY;

EID: 0038650972     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10194     Document Type: Conference Paper

References (54)

1. Abraham EH, Vos P, Kahn J, Grubman SA, Jefferson DM, Ding I, Okunieff P. 1996. Cystic fibrosis hetero- and homozygosity is associated with inhibition of breast cancer growth. Nature Med 1996;2(5):593-596.
2. Abraham EH, Sterling KM, Kim RJ, Salikhova AY, Huffman HB, Crockett MA, Johnston N, Parker HW, Boyle WE, Hartov A, Demidenko E, Efird J, Kahn J, Grubman SA, Jefferson DM, Robson SC, Thakar JH, Lorico A, Rappa G, Sartorelli AC, Okunieff P. 2001a. Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis. Blood Cells Molecules And Diseases, 27: (1) 165-180.
3. Abraham EH, Shrivastav B, Salikhova AY, Sterling KM, Johnston N, Guidotti G, Scala S, Litman T, Chan KC, Arceci RJ, Steiglitz K, Herscher L, Okunieff P. 2001b. Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes. Blood Cells Molecules And Diseases 27:(1)181-200.
4. Abraham EH, Salikhova A, Hartov A. 2002. Critical ATP parameters associated with blood and mammalian cells: relevant measurement techniques. Provisional patent with docket number 3418:1001-000.
5. Agteresch HJ, Dagnelie PC, Rietveld T, van den Berg JW, Danser AH, Wilson J H. 2000. Pharmacokinetics of intravenous ATP in cancer patients. Eur J Clin Pharmacol 56:49-55.
6. Bartlett DL, Stein TP, Torosian MH. 1995. Effect of growth hormone and protein intake on tumor growth and host cachexia. Surgery 117:260-267.
7. Capecchi PL, Laghi Pasini F, Sodi N, Chiavetta M, Sensi S, De Lalla A, Volpi L, Di Perri T. 1995. Increase in plasma levels of adenosine and adenine nucleotides after intravenous infusion of buflomedil in humans. J Cardiovasc Pharmacol 25:35-39.
8. Chagoya de Sanchez V, Hernandez-Munoz R, Suarez J, Vidrio S, Yanez L, Aguilar-Roblero R, Oksenberg A, Vega-Gonzalez A, Villalobos L, Rosenthal L, Fernandez-Cancino F, Drucker-Colin R, Diaz-Munoz M. 1996. Temporal variations of adenosine metabolism in human blood. Chronobiol Int 13:163-177.
9. Chapman AG, Fall L, Atkinson DE. 1971. Adenylate energy charge in Escherichia coh during growth and starvation. J Bacteriol 108:1072-1086.
10. Cole HA, Wimpenny JW, Hughes DE. 1967. The ATP pool in Escherichia coli. I. Measurement of the pool using modified luciferase assay. Biochim Biophys Acta 143:445-453.
11. Daneryd P, Westin T, Edstrom S, Soussi B. 1995. Tumour purine nucleotides and cell proliferation in response to exercise in rats. Eur J Cancer 31A:2309-2312.
12. Daneryd P, Svanberg E, Korner U, Lindholm E, Sandstrom R, Brevinge H, Pettersson C, Bosaeus I, Lundholm K. 1998. Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study. Cancer Res 58:5374-5379.
13. Davison JA, Fynn GH. 1974. The assay of ATP by the luciferin- luciferase method. Interference by a bacterial phosphatase enzyme stable to perchlorate treatment. Anal Biochem 58:632-637.
14. De la Morena Garcia E, Solano Calderon JR, Lomas Pico LA, Moneo Calvo FJ. 1977. [Levels of adenine nucleotide in erythrocytes of normal subjects and in neoplastic patients]. Rev Clin Esp 146:221-223.
15. Galloway SD, Tremblay MS, Sexsmith JR, Roberts CJ. 1996. The effects of acute phosphate supplementation in subjects of different aerobic fitness levels. Eur J Appl Physiol Occup Physiol 72:224-230.
16. Harkness RA, Simmonds RJ, Coade SB. 1983. Purine transport and metabolism in man: the effect of exercise on concentrations of purine bases, nucleosides and nucleotides in plasma, urine, leucocytes and erythrocytes. Clin Sci (Lond) 64:333-340.
17. Harkness RA, Coade SB, Webster AD. 1984. ATP, ADP and AMP in plasma from peripheral venous blood. Clin Chim Acta 143:91-98.
18. Hashimoto M, Shinozuka K, Tanabe Y, Gamoh S, Hara T, Hossain MS, Kwon YM, Kunitomo M, Masumura S. 1999. Hypotension induced by exercise is associated with enhanced release of adenyl purines from aged rat artery. Am J Physiol 276:H970-H975.
19. Holroyde CP, Reichard GA. 1981. Carbohydrate metabolism in cancer cachexia. Cancer Treat Rep 65(suppl 5):55-59.
20. Holroyde CP, Reichard GA Jr. 1986. General metabolic abnormalities in cancer patients: anorexia and cachexia. Surg Clin North Am 66:947-956.
21. Holroyde CP, Gabuzda TG, Putnam RC, Paul P, Reichard GA. 1975. Altered glucose metabolism in metastatic carcinoma. Cancer Res 35:3710-3714.
22. Holroyde CP, Myers RN, Smink RD, Putnam RC, Paul P, Reichard GA. 1977. Metabolic response to total parenteral nutrition in cancer patients. Cancer Res 37:3109-3914.
23. Holroyde CP, Skutches CL, Boden G, Reichard GA. 1984. Glucose metabolism in cachectic patients with colorectal cancer. Cancer Res 44:5910-5913.
24. Inculet RI, Peacock JL, Gorschboth CM, Norton JA. 1987. Gluconeogenesis in the tumor-influenced rat hepatocyte: importance of tumor burden, lactate, insulin, and glucagon. J Natl Cancer Inst 79:1039-1046.
25. Kichenin K, Seman M. 2000. Chronic oral administration of ATP modulates nucleoside transport and purine metabolism in rats. J Pharmacol Exp Ther 294:126-133.
26. Knofler R, Weissbach G, Kuhlisch E. 1996. Critical evaluation of the quantification of ATP release reaction in whole blood. Thromb Res 84:157-165.
27. Knofler R, Weissbach G, Kuhlisch E. 1997. Release of adenosine triphosphate by adenosine diphosphate in whole blood and in erythrocyte suspensions. Am J Hematol 56:259-265.
28. Knowles CJ, Smith L. 1970. Measurements of ATP levels of intact Azotobacter vinelandii under different conditions. Biochim Biophys Acta 197:152-160.
29. Komarova SV, Mosharov EV, Vitvitsky VM, Ataullakhanov FI. 1999. Adenine nucleotide synthesis in human erythrocytes depends on the mode of supplementation of cell suspension with adenosine. Blood Cells Mol Dis 25:170-179.
30. Koszegi T. 1988. Rapid bioluminescent measurement of human erythrocyte ATP content. Clin Chem 34:2578.
31. Koszegi T, Kellermayer M, Kovecs F, Jobst K. 1988. Bioluminescent monitoring of ATP release from human red blood cells treated with nonionic detergent. J Clin Chem Clin Biochem 26:599-604.
32. Laciak J, Witkowski S. 1966. [Studies on the content of adenine compounds in the erythrocytes in laryngeal cancer patients]. Otolaryngol Pol 20:269-275.
33. Lader AS, Prat AG, Jackson GR Jr, Chervinsky KL, Lapey A, Kinane TB, Cantiello HE 2000. Increased circulating levels of plasma ATP in cystic fibrosis patients. Clin Physiol 20:348-353.
34. Lonsdale D, Shamberger RJ, Stahl JP, Evans R. 1999. Evaluation of the biochemical effects of administration of intravenous nutrients using erythrocyte ATP/ADP ratios. Altern Med Rev 4:37-44.
35. Maresh CM, Armstrong LE, Hoffman JR, Hannon DR, Gabaree CL, Bergeron MF, Whittlesey MJ, Deschenes MR. 1994. Dietary supplementation and improved anaerobic performance. Int J Sport Nutr 4:387-397.
36. Moss AH, Solomons CC, Alfrey AC. 1979. Elevated plasma adenine nucleotide levels in chronic renal failure and their possible significance. Proc Clin Dial Transplant Forum 9:184-188.
37. Nelson KA. 2000. The cancer anorexia-cachexia syndrome. Semin Oncol 27:64-68.
38. Nelson KA. 2001. Modern management of the cancer anorexia- cachexia syndrome. Curr Pain Headache Rep 5:250-256.
39. Olsson T, Gulliksson H, Palmeborn M, Bergstrom K, Thore A. 1983. Methodological aspects on the firefly luciferase assay of adenine nucleotides in whole blood and red blood cells. Scand J Clin Lab Invest 43:657-664.
40. Peacock JL, Inculet RI, Corsey R, Ford DB, Rumble WF, Lawson D, Norton JA. 1987. Resting energy expenditure and body cell mass alterations in noncachectic patients with sarcomas. Surgery 102:465-472.
41. Plagemann PG, Wohlhueter RM, Kraupp M. 1985. Adenosine uptake, transport, and metabolism in human erythrocytes. J Cell Physiol 125:330-336.
42. Rabini RA, Petruzzi E, Staffolani R, Tesei M, Fumelli P, Pazzagli M, Mazzanti L. 1997. Diabetes mellitus and subjects' ageing: a study on the ATP content and ATP-related enzyme activities in human erythrocytes. Eur J Clin Invest 27:327-332.
43. Romanello M, Pani B, Bicego M, D'Andrea P. 2001. Mechanically induced ATP release from human osteoblastic cells. Biochem Biophys Res Commun 289:1275-1281.
44. Ryan LM, Rachow JW, McCarty BA, McCarty DJ. 1996. Adenosine triphosphate levels in human plasma. J Rheumatol 23:214-219.
45. Schneeberger AL, Thompson RT, Driedger AA, Finley RJ, Inculet RI. 1989. Effect of cancer on the in vivo energy state of rat liver and skeletal muscle. Cancer Res 49:1160-1164.
46. Seekamp A, Hildebrand F, van Griensven M, Grotz M, Tscherne H. 1999a. [Role of adenosine triphosphate (ATP) in trauma-induced and elective hypothermia]. Zentralbl Chir 124:1017-1029.
47. Seekamp A, van Griensven M, Hildebrandt F, Wahlers T, Tscherne H. 1999b. Adenosine-triphosphate in trauma-related and elective hypothermia. J Trauma 47:673-683.
48. Sprague RS, Stephenson AH, Ellsworth ML, Keller C, Lonigro AJ. 2001. Impaired release of ATP from red blood cells of humans with primary pulmonary hypertension. Exp Biol Med (Maywood) 226:434-439.
49. Stein TP. 1978. Cachexia, gluconeogenesis and progressive weight loss in cancer patients. J Theor Biol 73:51-59.
50. Stocchi V, Canestrari F, Giacchi R, Sebastiani M, Lungarotti F, Dacha U, Dacha M. 1987. Adenine and pyridine nucleotides in the red blood cells of subjects with solid tumors. Tumori 73:25-28.
51. Tomiya N, Ailor E, Lawrence SM, Betenbaugh MJ, Lee YC. 2001. Determination of nucleotides and sugar nucleotides involved in protein glycosylation by high-performance anion-exchange chromatography: sugar nucleotide contents in cultured insect cells and mammalian cells. Anal Biochem 293:129-137.
52. Torosian MH, Bartlett DL, Chatzidakis C, Stein TP. 1993. Effect of tumor burden on futile glucose and lipid cycling in tumor-bearing animals. J Surg Res 55:68-73.
53. Wagner DR, Felbel J, Gresser U, Zollner N. 1991. Muscle metabolism and red cell ATP/ADP concentration during bicycle ergometer in patients with AMPD-deficiency. Klin Wochenschr 69:251-255.
54. Wand H, Rieche K. 1972. [Content and liberation of adenine nucleotides from isolated thrombocytes of cancer patients prior and during treatment]. Dtsch Gesundheitsw 27:1072-1076.